1. Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis
   Yuanchun Zhao et al, 2022, Symmetry CrossRef
2. Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
   Dong Hoon Suh et al, 2013, Journal of Cancer Prevention CrossRef
3. Molecular Epigenetics in the Management of Ovarian Cancer: Are We Investigating a Rational Clinical Promise?
   Ha T. Nguyen et al, 2014, Frontiers in Oncology CrossRef
4. Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro
   Lulu Si et al, 2022, Frontiers in Pharmacology CrossRef
5. Valproic Acid Inhibits Peripheral T Cell Lymphoma Cells Behaviors via Restraining PI3K/AKT Pathway
   Zhiqiang Peng et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
   Iason Psilopatis et al, 2021, Disease Markers CrossRef
7. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
   Iason Psilopatis et al, 2022, International Journal of Molecular Sciences CrossRef
8. Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
   Yueming Zhang et al, 2021, Frontiers in Pharmacology CrossRef